To The Moon

Guest Speaker:Mingzhe Gu : A professional trader with 15 years of experience in equities and international futures. He serves as a guest lecturer for several major global exchanges, including the Chicago Mercantile Exchange (CME), and is also the founder of Win-at-the-Start Investment Academy. He is currently the General Manager of Shanghai Qigu Information Technology.As an active Chinese presence on international futures platforms, in 2021 he once again emerged as a leading competitor in a live trading competition’s overseas-markets division, taking multiple awards with ease: 7th place in the Global Heavyweight Group, 1st prize in CME COMEX Copper Options, 1st prize in 10-Year U.S. Treasury Options, and 2nd prize in NYMEX WTI Crude Oil Options.Yesterday, Master Gu reviewed the major globa

First, I want to share a screenshot from my previous analysis of silver and gold price action. In that earlier piece, I said silver’s short-term top—assuming the Fed did not turn more hawkish and there was no black-swan surge in the U.S. dollar—should be above 130, while gold could be headed above 5,000. A little over a week later, silver has already printed a new high, and gold has also surged well past 5,000. $白银主连 2603(SImain)$ $白银2603(SI2603)$ $2倍做多白银ETF-ProShares(AGQ)$ $白银ETF-iShares(SLV)$ $微白银主连 2603(SILmain)$

If this week’s earnings season were a movie, the plot twist just stunned the audience. The script was supposed to be simple: AI companies print money, and their stocks go up. Instead, we witnessed a brutal reality check. The "A-Students" of the AI world ( $ServiceNow(NOW)$, $Celestica(CLS)$, $SAP SE(SAP)$ ) delivered record-breaking report cards, only to be punished for not being perfect enough. The market punished them for the "sin" of high expectations, fearing that the cost of growth (CapEx) is becoming too high.Meanwhile, $Starbucks(SBUX)$ stumbled in with messy financials, but was welcomed with open arms simply for sho

Hi, Tigers 🐯 Despite ongoing cost pressures, the healthcare sector’s growth outlook remains constructive. An ageing population and continued breakthroughs in medical innovation continue to provide long-term support Looking to invest in this sector but don’t wanna pick individual stocks? ETFs offer a simple and cost-efficient way to gain exposure! Of course, near-term challenges are real.According to a McKinsey report dated 12 January, the US healthcare system is under increasing financial pressure. Industry operating margins are expected to fall from 11.2% in 2019 to 8.9% in 2024, with payers and healthcare providers most affected. However, analysts expect conditions to improve gradually over the next three years.With an ageing population and steady demand for new therapies, healthcare rem